Anti-aging research is primed to impact the global structure of healthcare, with the Harvard Gazette reporting a series of opportunities focused on extending the human lifespan. The Boston-based Academy for Health and Lifespan Research launched in February, with a dual focus on promoting future work in anti-aging medicine and ensuring the factuality of information being disseminated. Reflecting on the immeasurable progress made in the field of aging, founding member and Harvard Medical School Genetics Professor David Sinclair believes that “we can develop medicines that will treat aging at its source and thereby have a much greater impact on health and lifespan than drugs that target a single disease.”
Using Bacteria to Create Anti-Aging Pills
March 18, 2019